Boston Historical Balance Sheet

0HOY Stock   90.94  1.30  1.45%   
Trend analysis of Boston Scientific Corp balance sheet accounts such as Other Current Liab of 2.8 B, Total Current Liabilities of 4.1 B or Total Stockholder Equity of 12 B provides information on Boston Scientific's total assets, liabilities, and equity, which is the actual value of Boston Scientific Corp to its prevalent stockholders. By breaking down trends over time using Boston Scientific balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Boston Scientific Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Boston Scientific Corp is a good buy for the upcoming year.

Boston Scientific Inventory

1.45 Billion

  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Boston Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Boston Scientific Corp at a specified time, usually calculated after every quarter, six months, or one year. Boston Scientific Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Boston Scientific and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Boston currently owns. An asset can also be divided into two categories, current and non-current.

Boston Scientific Balance Sheet Chart

At this time, Boston Scientific's Short Term Investments are comparatively stable compared to the past year. Short Term Debt is likely to gain to about 711.3 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 2.8 B in 2024.

Total Assets

Total assets refers to the total amount of Boston Scientific assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Boston Scientific Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Cash

Cash refers to the most liquid asset of Boston Scientific Corp, which is listed under current asset account on Boston Scientific Corp balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Boston Scientific customers. The amounts must be unrestricted with restricted cash listed in a different Boston Scientific account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most accounts from Boston Scientific's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Boston Scientific's Short Term Investments are comparatively stable compared to the past year. Short Term Debt is likely to gain to about 711.3 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 2.8 B in 2024.
 2021 2022 2023 2024 (projected)
Other Current Liabilities2.7B2.4B3.2B2.8B
Total Assets32.2B32.5B35.1B26.4B

Boston Scientific balance sheet Correlations

0.550.590.990.980.820.940.90.711.00.510.950.710.90.970.630.830.920.570.910.960.950.310.780.960.67
0.550.90.490.540.750.50.670.570.550.750.490.570.680.560.340.580.560.060.490.650.590.050.640.630.88
0.590.90.520.560.750.530.670.550.590.670.490.550.750.60.390.510.59-0.060.470.680.570.230.550.680.81
0.990.490.520.990.760.930.910.690.990.460.930.690.880.980.630.780.930.590.930.910.950.220.790.920.6
0.980.540.560.990.760.940.930.650.980.490.920.650.910.990.650.760.960.530.940.90.940.20.840.90.62
0.820.750.750.760.760.740.740.60.820.850.760.60.840.780.320.940.760.330.650.880.770.320.720.890.83
0.940.50.530.930.940.740.850.630.940.520.990.630.870.920.80.770.880.520.950.90.890.350.820.90.64
0.90.670.670.910.930.740.850.660.90.550.810.650.920.950.60.690.920.320.880.820.860.050.810.820.68
0.710.570.550.690.650.60.630.660.670.460.651.00.490.650.390.650.490.660.710.710.85-0.060.520.710.57
1.00.550.590.990.980.820.940.90.670.510.940.670.920.970.630.830.930.530.890.960.930.350.760.970.67
0.510.750.670.460.490.850.520.550.460.510.520.460.610.530.170.780.540.150.470.580.550.010.730.580.74
0.950.490.490.930.920.760.990.810.650.940.520.650.830.90.750.820.850.590.920.930.90.40.780.910.63
0.710.570.550.690.650.60.630.651.00.670.460.650.490.650.390.650.490.660.710.710.85-0.060.520.710.57
0.90.680.750.880.910.840.870.920.490.920.610.830.490.940.640.720.940.190.810.870.790.330.810.880.75
0.970.560.60.980.990.780.920.950.650.970.530.90.650.940.640.760.970.460.930.890.920.190.830.910.67
0.630.340.390.630.650.320.80.60.390.630.170.750.390.640.640.290.60.260.780.590.570.340.590.580.49
0.830.580.510.780.760.940.770.690.650.830.780.820.650.720.760.290.710.560.690.870.810.290.70.870.71
0.920.560.590.930.960.760.880.920.490.930.540.850.490.940.970.60.710.350.870.830.850.180.880.840.63
0.570.06-0.060.590.530.330.520.320.660.530.150.590.660.190.460.260.560.350.610.50.71-0.060.380.520.19
0.910.490.470.930.940.650.950.880.710.890.470.920.710.810.930.780.690.870.610.810.920.060.850.820.62
0.960.650.680.910.90.880.90.820.710.960.580.930.710.870.890.590.870.830.50.810.90.480.70.990.77
0.950.590.570.950.940.770.890.860.850.930.550.90.850.790.920.570.810.850.710.920.90.10.80.910.66
0.310.050.230.220.20.320.350.05-0.060.350.010.4-0.060.330.190.340.290.18-0.060.060.480.1-0.040.450.23
0.780.640.550.790.840.720.820.810.520.760.730.780.520.810.830.590.70.880.380.850.70.8-0.040.70.66
0.960.630.680.920.90.890.90.820.710.970.580.910.710.880.910.580.870.840.520.820.990.910.450.70.78
0.670.880.810.60.620.830.640.680.570.670.740.630.570.750.670.490.710.630.190.620.770.660.230.660.78
Click cells to compare fundamentals

Boston Scientific Account Relationship Matchups

Boston Scientific balance sheet Accounts

201920202021202220232024 (projected)
Total Assets30.6B30.8B32.2B32.5B35.1B26.4B
Other Current Liab2.7B2.8B2.7B2.4B3.2B2.8B
Total Current Liabilities4.9B3.7B4.3B3.8B4.9B4.1B
Total Stockholder Equity13.9B15.3B16.6B17.6B19.3B12.0B
Property Plant And Equipment Net2.4B2.5B2.7B2.8B3.3B2.3B
Net Debt9.8B7.7B7.4B8.2B8.7B6.5B
Retained Earnings(2.3B)(2.4B)(1.4B)(750M)819M860.0M
Accounts Payable542M513M794M862M942M543.4M
Cash563M1.9B2.1B1.1B865M927.8M
Non Current Assets Total25.9B24.1B25.9B26.7B28.6B21.4B
Non Currrent Assets Other144M166M225M442M4.5B4.7B
Other Assets4.6B4.5B4.6B4.6B5.3B5.5B
Cash And Short Term Investments563M1.9B2.1B1.1B865M928.1M
Net Receivables1.9B1.5B1.8B2.0B2.2B1.7B
Good Will10.2B10.0B12.0B12.9B14.4B9.6B
Common Stock Shares Outstanding1.4B1.4B1.4B1.4B1.5B1.5B
Non Current Liabilities Total11.8B11.8B11.3B11.1B10.7B9.8B
Inventory1.6B1.4B1.6B1.9B2.5B1.5B
Other Current Assets624M2.3B1.2B1.3B937M949.8M
Other Stockholder Equity15.8B17.5B17.7B18.0B18.4B17.8B
Total Liab16.7B15.5B15.6B14.9B15.6B14.4B
Total Current Assets4.7B6.7B6.3B5.8B6.5B5.0B
Intangible Assets8.2B6.1B6.2B6.0B6.0B6.8B
Short Long Term Debt Total10.4B9.6B9.5B9.3B9.6B8.1B
Liabilities And Stockholders Equity30.6B30.8B32.2B32.5B35.1B27.1B
Accumulated Other Comprehensive Income270M207M263M268M50M47.5M
Short Term Debt1.5B83M332M81M607M711.3M
Long Term Debt3.8B4.8B8.6B9.1B10.5B7.0B
Capital Surpluse17.2B17.3B17.6B19.7B22.7B19.5B
Property Plant Equipment2.4B2.5B2.7B2.8B3.3B2.4B
Other Liab3.0B2.2B2.1B1.8B1.6B1.9B
Net Tangible Assets(4.5B)(760M)(1.6B)(1.3B)(1.5B)(1.6B)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.